SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 94 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,000 | -11.8% | 1,816,620 | 0.0% | 1.80% | +22.0% |
| Q2 2023 | $47,632 | +1.8% | 1,816,620 | -0.0% | 1.48% | -46.9% |
| Q1 2023 | $46,779 | -10.1% | 1,817,349 | -9.1% | 2.78% | -4.3% |
| Q4 2022 | $52,020 | -99.9% | 2,000,000 | -2.6% | 2.90% | +16.2% |
| Q3 2022 | $58,584,000 | +164.4% | 2,053,403 | +128.2% | 2.50% | +111.3% |
| Q2 2022 | $22,158,000 | -53.8% | 900,000 | +5.9% | 1.18% | -41.1% |
| Q1 2022 | $47,974,000 | -8.9% | 850,000 | 0.0% | 2.01% | +40.5% |
| Q4 2021 | $52,683,000 | +38.4% | 850,000 | +41.7% | 1.43% | +67.8% |
| Q3 2021 | $38,064,000 | -7.6% | 600,000 | +20.0% | 0.85% | +1.9% |
| Q2 2021 | $41,205,000 | +40.0% | 500,000 | +25.0% | 0.84% | +60.8% |
| Q1 2021 | $29,428,000 | -9.8% | 400,000 | -11.1% | 0.52% | -25.8% |
| Q4 2020 | $32,634,000 | +140.2% | 450,000 | +57.9% | 0.70% | +112.4% |
| Q3 2020 | $13,586,000 | +7.8% | 285,000 | -5.0% | 0.33% | -6.5% |
| Q2 2020 | $12,600,000 | +33.3% | 300,000 | -14.3% | 0.35% | -11.5% |
| Q1 2020 | $9,450,000 | -29.9% | 350,000 | 0.0% | 0.40% | -23.3% |
| Q4 2019 | $13,472,000 | +101.4% | 350,000 | +13.4% | 0.52% | +94.0% |
| Q3 2019 | $6,689,000 | – | 308,526 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 7,281,307 | $347,100,000 | 32.35% |
| BVF INC/IL | 2,053,991 | $97,914,000 | 5.33% |
| Samsara BioCapital, LLC | 398,017 | $18,973,000 | 5.29% |
| Orbimed Advisors | 7,406,307 | $353,059,000 | 4.44% |
| Consonance Capital Management LP | 602,732 | $28,732,000 | 3.50% |
| Boxer Capital, LLC | 2,075,905 | $98,958,000 | 3.42% |
| Perceptive Advisors | 3,481,148 | $165,946,000 | 2.42% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,234,262 | $58,837,000 | 1.43% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 974,915 | $46,474,000 | 0.95% |
| HighVista Strategies LLC | 11,477 | $547,000 | 0.40% |